Abstract Background: This study aimed to develop a comprehensive model based on five GLIM variables to predict the individual survival and provide more appropriate patient counseling. Methods: This retrospective cohort study included 210 gastric cancer (GC) patients undergoing radical resection, among whom 150 patients in the development cohort and 60 patients in the external validation cohort. C-reactive protein (CRP) as an inflammatory marker was included in GLIM criteria and a nomogram for predicting 5-year overall survival (OS) in GC patients was established. Results: Of the total 210 patients, 16 (7.62%) died within 5 years. CRP improved the sensitivity and accuracy of the survival prediction model (AUC=0.779, 0.563 to 0.849 for the model without CRP; AUC=0.896, 0.645 to 0.963 for the model adding CRP). Besides, a GLIM-based nomogram was established with an AUC of 0.896. The C-index for predicting OS was 0.804 (95% CI: 0.645 to 0.963), and the calibration curve fitted well. Decision curve analysis (DCA) showed the clinical utility of the nomogram based on GLIM. Conclusion: The addition of CRP improved the sensitivity and accuracy of the survival prediction model. The 5-year survival probability of GC patients undergoing radical resection can be reliably predicted by the nomogram presented in this study.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: